Additionally, there is no imaging equipment required for placement of the S-ICD Program, as all the components are positioned using anatomical landmarks. The S-ICD System received CE acceptance in 2009 and is available in Europe commercially. Most frequently, these leads, made of thin insulated wires, are threaded through a vein and placed inside the heart then. On the other hand, the Cameron Health S-ICD System resides slightly below the skin, potentially avoiding most of the complications linked to the conventional implant procedure. The company plans to sign up up to 330 subjects at up to 35 sites globally. The analysis has primary clinical endpoints of arrhythmia conversion complication and efficacy free rate at 6 months for patients vulnerable to SCA. Related StoriesBoston Children's and Rock Wellness team up to accelerate advancement of pediatric health technologiesGlan Clwyd Medical center N Wales invest in Esaote's G-Scan MRI device for weight-bearing scanningLoyola Medicine, Palos Community Medical center launch innovative telemedicine program jointly Jay Warren, CEO and President of Cameron Health, Inc.S., Europe and New Zealand.If the CDC and the drug companies wanted to win the vaccine wars really, as they say, all they would have to do is take the poisons from the vaccines! If that really happened, most of the resistance to vaccines would fade, and vaccines would be welcomed by a much larger segment of health-conscious customers. So why won’t the CDC and medication businesses remove mercury from flu pictures? Why won’t they remove aluminum, Formaldehyde and MSG from other vaccines? I honestly have no idea.